ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 184 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $2,273,000 | -17.6% | 26,600 | +11.8% | 0.02% | -21.4% |
Q2 2018 | $2,758,000 | +46.9% | 23,800 | +2.6% | 0.03% | +40.0% |
Q1 2018 | $1,877,000 | +36.4% | 23,200 | -1.1% | 0.02% | +33.3% |
Q4 2017 | $1,376,000 | +91.1% | 23,450 | +17.2% | 0.02% | +66.7% |
Q2 2017 | $720,000 | +16.9% | 20,000 | 0.0% | 0.01% | +28.6% |
Q1 2017 | $616,000 | -8.1% | 20,000 | 0.0% | 0.01% | -22.2% |
Q4 2016 | $670,000 | +25.9% | 20,000 | 0.0% | 0.01% | +12.5% |
Q3 2016 | $532,000 | +20.6% | 20,000 | 0.0% | 0.01% | +14.3% |
Q2 2016 | $441,000 | -24.9% | 20,000 | 0.0% | 0.01% | -30.0% |
Q1 2016 | $587,000 | -11.1% | 20,000 | 0.0% | 0.01% | -16.7% |
Q4 2015 | $660,000 | – | 20,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |